MOLECULAR BRAILLE

Welcome to the Brand page for “MOLECULAR BRAILLE”, which is offered here for Drug discovery services, screening nuclear receptors by using surrogate ligands to profile selective receptor modulators in vitro and classifying drug leads into groups of tissue selective agonists and antagonists;.

Its status is currently believed to be active. Its class is unavailable. “MOLECULAR BRAILLE” is believed to be currently owned by “KARO BIO AB”.


Owner:
KARO BIO AB
Owner Details
Description:
DRUG DISCOVERY SERVICES, SCREENING NUCLEAR RECEPTORS BY USING SURROGATE LIGANDS TO PROFILE SELECTIVE RECEPTOR MODULATORS IN VITRO AND CLASSIFYING DRUG LEADS INTO GROUPS OF TISSUE SELECTIVE AGONISTS AND ANTAGONISTS;
Categories: DRUG DISCOVERY SERVICES